188 In the index

Somatropin HGH

Recombinant human growth hormone, FDA-approved for growth hormone deficiency, certain growth disorders, and HIV-related wasting. Its approved uses are strongly supported by research, while off-label anti-aging or bodybuilding use carries documented risks like fluid retention, joint pain, and reduced sensitivity to insulin.

Also known as Human growth hormone, GH

Effects Build muscle Heal Lose fat

Routes Subcutaneous

Legal status Prescription drug

WADA Banned at all times

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 0.2-0.4 mg/day (adult GH deficiency, weight-based)

Reported range 0.15-1.5 mg/day depending on indication (adult vs. pediatric) and use case

Route Subcutaneous injection

Frequency Once daily

Duration Chronic/ongoing (as prescribed)

FDA-approved recombinant human growth hormone (Genotropin, Humatrope, and others) for diagnosed GH deficiency and specific other conditions; off-label bodybuilding/anti-aging use is common but unsupervised and uses doses well above approved replacement levels in some cases.

Where this comes from FDA prescribing information; off-label user-reported dosing

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.

Variants

Name	Abbr	Route	Notes
Somatropin (rDNA)	HGH-R	Subcutaneous	Recombinant human GH, the standard pharmaceutical form.